Difference between revisions of "Tropisetron (Navoban)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "5HT3" to "5-HT3") |
m |
||
| Line 1: | Line 1: | ||
==Mechanism of action== | ==Mechanism of action== | ||
[http://www.cancer.gov/drugdictionary?CdrID=43507 From NCI]: "An indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in suppression of chemotherapy-and radiotherapy-induced nausea and vomiting." | [http://www.cancer.gov/drugdictionary?CdrID=43507 From NCI]: "An indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in suppression of chemotherapy-and radiotherapy-induced nausea and vomiting." | ||
| − | |||
| − | |||
| − | |||
==Also known as== | ==Also known as== | ||
| − | ICS 205-930, Setrovel | + | *'''Code name:''' ICS 205-930 |
| + | *'''Brand names:''' Abatoarin, Hensetron, Navoban, Setrovel | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
| + | [[Category:Oral medications]] | ||
| + | [[Category:Intravenous medications]] | ||
| + | |||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Serotonin 5-HT3 antagonists]] | [[Category:Serotonin 5-HT3 antagonists]] | ||
| + | |||
| + | [[Category:EMA approved drugs]] | ||
| + | [[Category:PMDA approved drugs]] | ||
| + | [[Category:KFDA approved drugs]] | ||
Revision as of 16:05, 3 December 2017
Mechanism of action
From NCI: "An indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in suppression of chemotherapy-and radiotherapy-induced nausea and vomiting."
Also known as
- Code name: ICS 205-930
- Brand names: Abatoarin, Hensetron, Navoban, Setrovel